Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PERRIGO COMPANY PLC

(PRGO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

PERRIGO COMPANY PLC : Ex-dividend day for

06/03/2021 EDT

A dividend is removed today from Perrigo Company plc's share.



ę Factset 2021
All news about PERRIGO COMPANY PLC
08/03PERRIGO : Announces Quarterly Dividend
PR
07/28PERRIGO : To Release Second Quarter 2021 Financial Results On August 11, 2021
PR
07/22AMERICAN VIRTUAL CLOUD TECHNOLOGIES : Reshuffles Board, Senior Management, Share..
MT
07/14PERRIGO : Thinking about trading options or stock in Apple, Boeing, Perrigo, Mas..
PR
07/13PERRIGO CO PLC : Regulation FD Disclosure (form 8-K)
AQ
07/12PERRIGO CO PLC : Entry into a Material Definitive Agreement, Completion of Acqui..
AQ
07/06PERRIGO : Completes Generic Rx Pharmaceuticals Business Sale For $1.55 Billion
MT
07/06PERRIGO : Completes Divestiture Of Generic Rx Business For $1.55 Billion
PR
07/06Altaris Capital Partners, LLC completed the acquisition of Generic Rx Pharmac..
CI
06/21U.S. Supreme Court rebuffs AbbVie appeal in patent fight involving AndroGel d..
RE
More news
Financials (USD)
Sales 2021 4 205 M - -
Net income 2021 194 M - -
Net Debt 2021 1 602 M - -
P/E ratio 2021 -45,9x
Yield 2021 2,09%
Capitalization 6 380 M 6 380 M -
EV / Sales 2021 1,90x
EV / Sales 2022 1,76x
Nbr of Employees 11 500
Free-Float 98,8%
Chart PERRIGO COMPANY PLC
Duration : Period :
Perrigo Company plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PERRIGO COMPANY PLC
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Last Close Price 47,77 $
Average target price 52,00 $
Spread / Average Target 8,85%
EPS Revisions
Managers and Directors
Murray S. Kessler President, Chief Executive Officer & Director
Raymond P. Silcock CFO, Principal Accounting Officer & Executive VP
Rolf Allan Classon Chairman
Thomas M. Farrington Chief Information Officer & Executive VP
Grainne Quinn Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
PERRIGO COMPANY PLC6.82%6 505
JOHNSON & JOHNSON10.81%459 079
ROCHE HOLDING AG14.16%340 492
PFIZER, INC.24.10%255 703
ELI LILLY AND COMPANY51.62%232 701
NOVARTIS AG-0.20%224 638